158 related articles for article (PubMed ID: 35611468)
1. Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma.
Yusa T; Yamashita YI; Okabe H; Nakao Y; Itoyama R; Kitano Y; Kaida T; Miyata T; Mima K; Imai K; Hayashi H; Baba H
Cancer Sci; 2022 Dec; 113(12):4048-4058. PubMed ID: 35611468
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
4. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.
Kitano Y; Okabe H; Yamashita YI; Nakagawa S; Saito Y; Umezaki N; Tsukamoto M; Yamao T; Yamamura K; Arima K; Kaida T; Miyata T; Mima K; Imai K; Hashimoto D; Komohara Y; Chikamoto A; Ishiko T; Baba H
Br J Cancer; 2018 Jan; 118(2):171-180. PubMed ID: 29123259
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.
Chen KJ; Zhou L; Xie HY; Ahmed TE; Feng XW; Zheng SS
Med Oncol; 2012 Sep; 29(3):1817-26. PubMed ID: 21678026
[TBL] [Abstract][Full Text] [Related]
8. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.
Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X
Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849
[TBL] [Abstract][Full Text] [Related]
9. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Zhu XD; Zhang JB; Zhuang PY; Zhu HG; Zhang W; Xiong YQ; Wu WZ; Wang L; Tang ZY; Sun HC
J Clin Oncol; 2008 Jun; 26(16):2707-16. PubMed ID: 18509183
[TBL] [Abstract][Full Text] [Related]
10. [Tumor-infiltrating FoxP3+ Tregs are associated with CD34 expression and prognosis of hepatocellular carcinoma].
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; DU Z
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):25-9. PubMed ID: 22464702
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis.
Schoenberg MB; Li X; Li X; Han Y; Hao J; Miksch RC; Koch D; Börner N; Beger NT; Bucher JN; Schiergens TS; Guba MO; Werner J; Bazhin AV
Eur J Surg Oncol; 2021 Oct; 47(10):2561-2570. PubMed ID: 33966947
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine Tumor.
Zhang WH; Wang WQ; Gao HL; Xu SS; Li S; Li TJ; Han X; Xu HX; Li H; Jiang W; Ye LY; Lin X; Wu CT; Yu XJ; Liu L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32285127
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.
Shi J; Wang Y; Wang F; Zhu Z; Gao Y; Zhang Q; Du Z
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):855-864. PubMed ID: 32205116
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.
Dai XM; Huang T; Yang SL; Zheng XM; Chen GG; Zhang T
Dis Markers; 2017; 2017():8495326. PubMed ID: 28572700
[TBL] [Abstract][Full Text] [Related]
16. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
18. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
[TBL] [Abstract][Full Text] [Related]
19. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma.
Zhang T; Lei X; Jia W; Li J; Nie Y; Mao Z; Wang Y; Tao K; Song W
Cancer Med; 2023 Feb; 12(3):3068-3078. PubMed ID: 36082777
[TBL] [Abstract][Full Text] [Related]
20. Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.
Hu ZQ; Xin HY; Luo CB; Li J; Zhou ZJ; Zou JX; Zhou SL
Cancer Immunol Immunother; 2021 Feb; 70(2):377-389. PubMed ID: 32761426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]